Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5438-41-5

Post Buying Request

5438-41-5 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

5438-41-5 Usage

Description

5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE is an organic compound derived from 3,4-Methylenedioxy Methamphetamine (M303985) and is characterized by its yellow solid appearance. It is known for its inhibitory effects on hepatic microsomal enzyme function in mice, which can be significant in various applications.

Uses

Used in Pharmaceutical Industry:
5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE is used as a research chemical for its inhibitory properties on hepatic microsomal enzyme function in mice. This application is crucial in the development of new drugs and therapies, as it can help understand the metabolic pathways and potential interactions with other compounds.
Used in Chemical Research:
As a byproduct of 3,4-Methylenedioxy Methamphetamine (M303985), 5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE can be utilized in chemical research to explore its properties, reactivity, and potential applications in various chemical processes and reactions.
Used in Toxicology Studies:
Due to its origin from a psychoactive substance, 5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE can be employed in toxicology studies to investigate the effects of its parent compound and related substances on biological systems, potentially leading to a better understanding of their mechanisms of action and safety profiles.
Used in Environmental Monitoring:
The chemical properties of 5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE, including its solid state and color, make it a candidate for environmental monitoring applications, where it could be used to detect or quantify the presence of specific contaminants or pollutants in various samples.
Used in Material Science:
The unique properties of 5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE may also find applications in material science, where it could be used to develop new materials with specific characteristics, such as improved stability, reactivity, or selectivity in various chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 5438-41-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,3 and 8 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5438-41:
(6*5)+(5*4)+(4*3)+(3*8)+(2*4)+(1*1)=95
95 % 10 = 5
So 5438-41-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO4/c1-7(11(12)13)4-8-2-3-9-10(5-8)15-6-14-9/h2-5H,6H2,1H3/b7-4+

5438-41-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(2-Nitroprop-1-en-1-yl)benzo[d][1,3]dioxole

1.2 Other means of identification

Product number -
Other names 5-(2-NITROPROP-1-ENYL)-1,3-BENZODIOXOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5438-41-5 SDS

5438-41-5Relevant articles and documents

Synthesis, antimicrobial study, and molecular docking simulation of 3,4-dimethoxy-β-nitrostyrene derivatives as candidate ptp1b inhibitor

Alfarisi, Salman,Santoso, Mardi,Kristanti, Alfinda Novi,Siswanto, Imam,Puspaningsih, Ni Nyoman Tri

, p. 1 - 14 (2020/09/09)

A derivative series of 3,4-dimethoxy-β-nitrostyrene was synthesized through nitroaldol reaction, including a new compound of 3,4-ethylenedioxy-β-bromo-β-nitrostyrene. The antimicrobial activity effect of 3,4-alkyloxy modification of β-nitrostyrene was investigated. A molecular docking study was also performed to obtain information about their interactions with protein tyrosine phosphatase 1B (PTP1B). The active residues of cysteine-215 and arginine-221 of PTP1B play a key role in signaling pathways that regulate various microorganism cell functions. It also acts as a negative regulator in signaling pathways of insulin that are involved in type 2 diabetes and other metabolic diseases. These derivatives exhibited potential antifungal activity. The studied compounds were also had potential as fragments to be PTP1B inhibitors by interacting with serine-216 and arginine-221 residues, according to their molecular docking. 3,4-Ethylenedioxy-β-methyl-β-nitrostyrene was the most successful potential candidate as a PTP1B inhibitor. However, further research is needed to investigate their potential for medicinal use.

Substrate promiscuity of ortho-naphthoquinone catalyst: Catalytic aerobic amine oxidation protocols to deaminative cross-coupling and n-nitrosation

Kim, Hun Young,Oh, Kyungsoo,Si, Tengda

, p. 9216 - 9221 (2019/10/08)

ortho-Naphthoquinone-based organocatalysts have been identified as versatile aerobic oxidation catalysts. Primary amines were readily cross-coupled with primary nitroalkanes via deaminative pathway to give nitroalkene derivatives in good to excellent yields. Secondary and tertiary amines were inert to ortho-naphthoquinone catalysts; however, secondary nitroalkanes were readily converted by ortho-naphthoquinone catalysts to the corresponding nitrite species that in situ oxidized the amines to the corresponding N-nitroso compounds. Without using harsh oxidants in a stoichiometric amount, the present catalytic aerobic oxidation protocol utilizes the substrate promiscuity feature to provide a facile access to amine oxidation products under mild reaction conditions.

ANTIMICROBIAL AND RADIOPROTECTIVE COMPOUNDS

-

Paragraph 0117-0133, (2015/11/09)

The present invention relates to a method of treatment and/or prophylaxis of a microbial infection, comprising the step of administering an effective amount of a compound of formula (I), in which X and Y are either the same or different and selected from a heteroatom; is a double or single bond depending on the heteroatoms X and Y; R1 to R5 are either the same or different and selected from hydrogen or a non-deleterious substituent; and R6 and R7 are either the same or different and selected from hydrogen and a non-deleterious substituent or one of R6 and R7 are absent when there is a double bond present, pharmaceutically acceptable salts or derivatives, pro-drugs, tautomers and/or isomers thereof. The present invention also relates to a method for protecting a subject from radiation damage, a method of cancer radiotherapy and use as an antimicrobial or radioprotective agent of the compound of formula (I) defined above. Some of the compounds of formula (I) are novel and are also described in the present invention, together with pharmaceutical or veterinary compositions containing them.